News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,866 Results
Type
Article (54239)
Company Profile (289)
Press Release (700338)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (216288)
Career Advice (2889)
Deals (37383)
Drug Delivery (119)
Drug Development (86281)
Employer Resources (185)
FDA (17176)
Job Trends (15930)
News (367654)
Policy (35662)
Tag
Academia (2933)
Academic (1)
Accelerated approval (5)
Adcomms (27)
Allergies (93)
Alliances (52998)
ALS (98)
Alzheimer's disease (1478)
Antibody-drug conjugate (ADC) (143)
Approvals (17149)
Artificial intelligence (280)
Autoimmune disease (26)
Automation (16)
Bankruptcy (388)
Best Places to Work (12208)
BIOSECURE Act (20)
Biosimilars (116)
Biotechnology (206)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (295)
Cancer (2381)
Cardiovascular disease (197)
Career advice (2426)
Career pathing (33)
CAR-T (167)
Cell therapy (460)
Cervical cancer (21)
Clinical research (69939)
Collaboration (880)
Company closure (1)
Compensation (540)
Complete response letters (26)
COVID-19 (2805)
CRISPR (47)
C-suite (262)
Cystic fibrosis (104)
Data (2255)
Decentralized trials (2)
Denatured (22)
Depression (53)
Diabetes (289)
Diagnostics (6741)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (129)
Drug pricing (119)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (88841)
Editorial (44)
Employer branding (24)
Employer resources (158)
Events (119474)
Executive appointments (767)
FDA (18479)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (787)
Gene editing (115)
Generative AI (24)
Gene therapy (339)
GLP-1 (816)
Government (4884)
Grass and pollen (6)
Guidances (67)
Healthcare (20177)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2960)
Inflammatory bowel disease (151)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (100)
Interviews (560)
IPO (17010)
IRA (47)
Job creations (4146)
Job search strategy (2000)
Kidney cancer (11)
Labor market (38)
Layoffs (523)
Leadership (23)
Legal (8793)
Liver cancer (81)
Lung cancer (340)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (326)
MASH (74)
Medical device (14100)
Medtech (14105)
Mergers & acquisitions (20916)
Metabolic disorders (755)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (32)
Neuroscience (2067)
NextGen: Class of 2025 (7155)
Non-profit (4915)
Now hiring (39)
Obesity (406)
Opinion (255)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (86)
Parkinson's disease (158)
Partnered (21)
Patents (244)
Patient recruitment (115)
Peanut (51)
People (62229)
Pharmaceutical (69)
Pharmacy benefit managers (20)
Phase I (21706)
Phase II (30657)
Phase III (22966)
Pipeline (1242)
Policy (161)
Postmarket research (2945)
Preclinical (9321)
Press Release (71)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (256)
Rare diseases (415)
Real estate (6468)
Recruiting (73)
Regulatory (24241)
Reports (48)
Research institute (2579)
Resumes & cover letters (456)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (79)
Series A (137)
Series B (89)
Service/supplier (14)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (159)
Sponsored (32)
Startups (3886)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (44)
The Weekly (52)
Vaccines (779)
Venture capitalists (42)
Weight loss (281)
Women's health (36)
Worklife (19)
Date
Today (6)
Last 7 days (924)
Last 30 days (2632)
Last 365 days (33980)
2025 (11226)
2024 (36712)
2023 (41657)
2022 (52887)
2021 (57588)
2020 (56506)
2019 (49792)
2018 (37697)
2017 (34571)
2016 (34528)
2015 (40569)
2014 (34497)
2013 (29918)
2012 (31977)
2011 (32551)
2010 (30665)
Location
Africa (931)
Alabama (54)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (42806)
Australia (7772)
California (6258)
Canada (2044)
China (549)
Colorado (274)
Connecticut (281)
Delaware (155)
Europe (95869)
Florida (925)
Georgia (217)
Idaho (61)
Illinois (580)
India (27)
Indiana (323)
Iowa (11)
Japan (166)
Kansas (106)
Kentucky (26)
Louisiana (10)
Maine (62)
Maryland (936)
Massachusetts (4706)
Michigan (227)
Minnesota (411)
Mississippi (2)
Missouri (89)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1763)
New Mexico (30)
New York (1789)
North Carolina (1055)
North Dakota (8)
Northern California (2727)
Ohio (207)
Oklahoma (14)
Oregon (37)
Pennsylvania (1402)
Puerto Rico (13)
Rhode Island (35)
South America (1313)
South Carolina (24)
South Dakota (1)
Southern California (2348)
Tennessee (104)
Texas (923)
United States (23842)
Utah (185)
Virginia (153)
Washington D.C. (67)
Washington State (574)
West Virginia (3)
Wisconsin (56)
754,866 Results for "hanger inc formerly known as hanger orthopedic group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Hanger Announces Pete Stoy as CEO
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer, effective immediately.
May 1, 2023
·
2 min read
Deals
Hanger, Inc. Stockholders Approve Acquisition by Patient Square Capital
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm.
September 30, 2022
·
6 min read
Deals
Hanger, Inc. Completes Acquisition by Patient Square Capital
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction.
October 3, 2022
·
6 min read
Business
Hanger Announces CEO Transition Plan
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced Chairman and Chief Executive Officer Vinit Asar will retire from the role of CEO effective May 1, 2023 after more than a decade in the position.
January 18, 2023
·
3 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
·
10 min read
Press Releases
Devonian Health Group Inc. Reports Superior Anti-Inflammatory Potency of Thykamine™ in Comparative In Vitro Study
February 5, 2025
·
8 min read
1 of 75,487
Next
